US Pharma MarketingThe post FDA clears Bright Uro’s abdominal sensor for evaluating bladder dysfunction appeared first on Medical Device Network.
FDA clears Bright Uro’s abdominal sensor for evaluating bladder dysfunction
The approval of Bright Uro’s Glean abdominal sensor advances the capabilities of its broader Glean urodynamics system that gained FDA approval in March 2025. The approval of Bright Uro’s Glean abdominal sensor advances the capabilities of its broader Glean urodynamics system that gained FDA approval in March 2025. In the US, around 80 million individuals suffer from voiding problems such as urinary incontinence, according to the National Association for Continence. Credit: Jannissimo / Shutterstock.com Bright Uro’s Glean abdominal sensor has obtained US Food and Drug Administration (FDA) clearance, expanding the company’s broader Glean urodynamics system to include multi-channel urodynamic and…
The approval of Bright Uro’s Glean abdominal sensor advances the capabilities of its broader Glean urodynamics system that gained FDA approval in March 2025.
Source: Medical Device Network